Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Liabilities and Shareholders Equity (2016 - 2025)

HealthLynked (HLYK) has disclosed Liabilities and Shareholders Equity for 10 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 23.42% to $1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.4 million through Dec 2025, down 42.09% year-over-year, with the annual reading at $1.7 million for FY2025, 23.42% down from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $1.7 million at HealthLynked, down from $1.8 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $13.0 million in Q3 2021, with the low at $1.7 million in Q4 2025.
  • Average Liabilities and Shareholders Equity over 5 years is $5.8 million, with a median of $5.1 million recorded in 2022.
  • The sharpest move saw Liabilities and Shareholders Equity soared 376.54% in 2021, then crashed 57.17% in 2022.
  • Over 5 years, Liabilities and Shareholders Equity stood at $10.7 million in 2021, then plummeted by 57.17% to $4.6 million in 2022, then fell by 6.56% to $4.3 million in 2023, then tumbled by 48.06% to $2.2 million in 2024, then decreased by 23.42% to $1.7 million in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $1.7 million, $1.8 million, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.